Clinical Study of Apatinib Mesylate in the Treatment of Platinum Resistant Recurrent Ovarian Cancer
Condition: Ovarian Cancer Intervention: Drug: Apatinib mesylate Sponsor: First Affiliated Hospital of Harbin Medical University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials